Intercellular adhesion molecule-1 as a drug target in asthma and rhinitis

Respirology

Volumn 19, Issue 4, 2014, Pages 508-513

  Mukhopadhyay, Srirupa ^a   Malik, Parth ^b   Arora, Sunil K ^a   Mukherjee, Tapan K ^c  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b CENTRAL UNIVERSITY OF GUJARAT   (India)

^c MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

Author keywords

asthma; human rhinovirus; ICAM 1; inflammation; rhinitis.

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; CELL ADHESION MOLECULE; IMMUNOLOGIC FACTOR;

ASTHMA; DISEASE CONTROL; DISEASE EXACERBATION; DRUG TARGETING; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHINITIS; RHINOVIRUS; ANTAGONISTS AND INHIBITORS; CELL COMMUNICATION; COMMON COLD; COMPLICATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOGENICITY; RESPIRATORY TRACT MUCOSA; VIROLOGY;

ASTHMA; CELL ADHESION MOLECULES; CELL COMMUNICATION; COMMON COLD; HUMANS; IMMUNOLOGIC FACTORS; INTERCELLULAR ADHESION MOLECULE-1; MOLECULAR TARGETED THERAPY; RESPIRATORY MUCOSA; RHINITIS; RHINOVIRUS;

EID: 84899110414     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12285     Document Type: Review

References (67)

1. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA,. Primary structure of intercellular adhesion molecule 1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52: 925-933.
2. Witkowska AM, Borawska MH,. Soluble intercellular adhesion molecule-1: an overview. Eur. Cytokine Netw. 2004; 15: 91-98.
3. Smith CW, Marlin SD, Rothlein R, Toman C, Anderson DC,. Co-operative interaction of LFA-1 and Mac-1 with ICAM1 in facilitating adhesion and trans endothelia migration of human neutrophils in vitro. J. Clin. Invest. 1989; 83: 2008-2017.
4. Marlin SD, Springer TA,. Purified ICAM1 is a ligand for LFA-1. Cell 1987; 51: 813-819.
5. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC,. Regulation of leukocyte-endothelial interaction and leukocyte trans endothelial migration by ICAM1-fibrinogen recognition. Proc. Natl Acad. Sci. U.S.A. 1995; 92: 1505-1509.
6. Greve JM, Davis G, Meyer AM, Forte CP, Yost SC, Marlor CW, Kamarck ME, McClelland A,. The major human rhinovirus receptor is ICAM1. Cell 1989; 56: 839-847.
7. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA,. A cell adhesion molecule ICAM1 is the major surface receptor for rhinovirus. Cell 1989; 56: 849-853.
8. Springer TA,. The sensation and regulation of interactions with the extracellular environment: the cell biology of lymphocyte adhesion receptors. Annu. Rev. Cell Biol. 1990; 6: 359-402.
9. Dustin ML, Bivona TG, Philips MR,. Membranes as messengers in T cell adhesion signaling. Nat. Immunol. 2004; 5: 363-372.
10. Sligh JE Jr, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL,. Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc. Natl Acad. Sci. U.S.A. 1993; 90: 8529-8533.
11. Bartlett NW, Walton RP, Edwards MR, Aniscenko J, Caramori G, Zhu J, Glanville N, Choy KJ, Jourdan P, Burnet J, et al. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 2008; 14: 199-204.
12. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA,. Induction by IL-1 and IFN-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986; 137: 245-254.
13. Munro JM, Pober JS, Cotran RS,. Tumor necrosis factor and interferon-γ induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Pabio anubis. Am. J. Pathol. 1989; 135: 121-133.
14. Hubbard AK, Rothlein R,. Intercellular adhesion molecule- 1 expression and cell signaling cascades. Free Radic. Biol. Med. 2000; 28: 1379-1386.
15. Sabatini F, Silvestri M, Sale R, Scarso L, Defilippi AC, Risso FM, Rossi GA,. Fibroblast-eosinophil interaction. Modulation of adhesion molecules expression and chemokine release by human fetal lung fibroblasts in response to IL-4 and TNF-alpha. Immunol. Lett. 2002; 84: 173-178.
16. Gern JE, Busse WW,. Association of rhinovirus infections with asthma. Clin. Microbiol. Rev. 1999; 12: 9-18.
17. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am. J. Respir. Crit. Care Med. 2008; 178: 667-672.
18. Tamaya M, Sasaki H,. Rhinovirus and asthma. Viral Immunol. 2003; 16: 99-109.
19. Bella J, Rossmann MG,. ICAM-1 receptors and cold viruses. Pharm. Acta Helv. 2000; 74: 291-297.
20. Ciebiada M, Gorska-Ciebiada M, Gorski P,. sICAM-1 and TNF-α in asthma and rhinitis: relationship with the presence of atopy. J. Asthma 2011; 48: 660-666.
21. Broide DH, Sullivan S, Gifford T, Sriramarao P,. Inhibition of pulmonary eosinophilia in P-selectin- and ICAM-1-deficient mice. Am. J. Respir. Cell Mol. Biol. 1998; 18: 218-225.
22. Chihara J,. The roles of adhesion molecules, cytokines, and chemokines in eosinophil activation during allergic inflammation. Nihon Kyobu Shikkan Gakkai Zasshi 1996; 34: 116-120.
23. Stanciu LA, Djukanovic R,. The role of ICAM-1 on T-cells in the pathogenesis of asthma. Eur. Respir. J. 1998; 11: 949-957.
24. Grzelewska-Rzymowska I, Pietrzkowicz M,. Role of intra cellular adhesion molecule-1 (ICAM-1) and its soluble form (sICAM) in chronic airway inflammation. Pol. Merkur. Lekarski. 2004; 16: 179-182.
25. Oymar K, Bjerknes R,. Differential patterns of circulating adhesion molecules in children with bronchial asthma and acute bronchitis. Pediatr. Allergy Immunol. 1998; 9: 73-79.
26. Tang RB, Chen SJ, Soong WJ, Chung RL,. Circulating adhesion molecules in sera of asthmatic children. Pediatr. Pulmonol. 2002; 33: 249-254.
27. DoEgu F, Ikincio Egullari A, et al. Circulating adhesion molecule levels in childchood asthma. Indian Pediatr. 2002; 39: 1017-1021.
28. Kose S, Karaman O, Islekel H, Uzuner N, Babayigit A, Olmez D, Altun Z, Turgut S, Tezcan D,. Circulating adhesion molecules in sera of asthmatic children before and after steroid therapy. Allergy Asthma Proc. 2007; 28: 199-203.
29. Bijanzadeh M, Ramachandra NB, Mahesh PA, Savitha MR, Vijayakumar GS, Kumar P, Manjunath BS, Jayaraj BS,. Soluble intercellular adhesion molecule-1 and E-selectin in patients with asthma exacerbation. Lung 2009; 187: 315-320.
30. Chai OH, Han EH, Lee HK, Song CH,. Mast cells play a key role in Th2 cytokine-dependent asthma model through production of adhesion molecules by liberation of TNF-α. Exp. Mol. Med. 2011; 43: 35-43.
31. Desai D, Gupta S, Siddiqui S, Singapuri A, Monteiro W, Entwisle J, Visvanathan S, Parmar H, Kajekar R, Brightling CE,. Sputum mediator profiling and relationship to airway wall geometry imaging in severe asthma. Respir. Res. 2013; 11: 14-17.
32. Yamaya M,. Virus infection-induced bronchial asthma exacerbation. Pulm. Med. Arthritis Rheum. 1994; 37: 992-999.
33. Arden KE, McErlean P, Nissen MD, Sloots TP, Mackay IM,. Frequent detection of human rhinoviruses, paramyxoviruses, coronaviruses, and bocavirus during acute respiratory tract infections. J. Med. Virol. 2006; 78: 1232-1240.
34. Winther B, Hayden FG, Hendley JO,. Picornavirus infections in children diagnosed by RT-PCR during longitudinal surveillance with weekly sampling: Association with symptomatic illness and effect of season. J. Med. Virol. 2006; 78: 644-650.
35. Khetsuriani N, Kazerouni NN, Erdman DD, Lu X, Redd SC, Anderson LJ, Teague WG,. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 2007; 119: 314-321.
36. Palmenberg AC, Spiro D, Kuzmickas R, Wang S, Djikeng A, Rathe JA, Fraser-Liggett CM, Liggett SB,. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science 2009; 324: 55-59.
37. Vareille M, Kieninger E, Edwards MR, Regamey N,. The airway epithelium: Soldiers in the fight against respiratory viruses. Clin. Microbiol. Rev. 2011; 24: 210-229.
38. Subauste MC, Jacoby DB, Richards SM, Proud D,. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 1995; 96: 549-557.
39. Calhoun WJ, Swenson CA, Dick EC, Schwartz LB, Lemanske RF Jr, Busse WW,. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am. Rev. Respir. Dis. 1991; 144: 1267-1273.
40. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST,. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am. J. Respir. Crit. Care Med. 1995; 151: 879-886.
41. Gouw HWFM, Grünberg K, Schot R, Kroes ACM, Dick EC, Sterk PJ,. Relationship between exhaled nitric oxide and airway hyperresponsiveness following experimental rhinovirus infection in asthmatic subjects. Eur. Respir. J. 1998; 11: 126-132.
42. Hakonarson H, Maskeri N, Carter C, Hodinka RL, Campbell D, Grunstein MM,. Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness. J. Clin. Invest. 1998; 102: 1732-1741.
43. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE,. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J. Exp. Med. 2005; 201: 937-947.
44. Kim WK, Gern JE,. Updates in the relationship between human rhinovirus and asthma. Allergy Asthma Immunol. Res. 2012; 4: 116-121.
45. Gavala ML, Bertics PJ, Gern JE,. Rhinoviruses, allergic inflammation, and asthma. Immunol. Rev. 2011; 242: 69-90.
46. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O'Toole S, Myint SH, Tyrrell DA,. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310: 1225-1229.
47. Nicholson KG, Kent J, Ireland DC,. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307: 982-986.
48. Lin DC, Chandra RK, Tan BK, Zirkle W, Conley DB, Grammer LC, Kern RC, Schleimer RP, Peters AT,. Association between severity of asthma and degree of chronic rhinosinusitis. Am. J. Rhinol. Allergy 2011; 25: 205-208.
49. Martin S, Casasnovas JM, Staunton DE, Springer TA,. Efficient neutralization and disruption of rhinovirus by chimeric ICAM-1/immunoglobulin molecules. J. Virol. 1993; 67: 3561-3568.
50. Whiteman SC, Spiteri MA,. IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM-1 release inhibits human rhinovirus infection. J. Inflamm. 2008; 5: 8.
51. Whiteman SC, Bianco A, Knight RA, Spiteri MA,. Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J. Biol. Chem. 2003; 278: 11954-11961.
52. Walter MJ, Morton JD, Kajiwara N, Agapov E, Holtzman MJ,. Viral induction of a chronic asthma phenotype and genetic segregation from acute response. J. Clin. Invest. 2002; 110: 165-175.
53. Nurani G, Lindqvist B, Casasnovas JM, Receptor Priming of Major Group. Human rhinoviruses for uncoating and entry at mild low-pH environments. J. Virol. 2003; 77: 11985-11991.
54. Hoover-Litty H, Greve JM,. Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J. Virol. 1993; 67: 390-397.
55. Xing L, Casasnovas JM, Cheng RH,. Structural analysis of human rhinovirus complexed with ICAM-1 reveals the dynamics of receptor-mediated virus uncoating. J. Virol. 2003; 77: 6101-6107.
56. Zimmerman T, Blanco FJ,. Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action. Curr. Pharm. Des. 2008; 14: 2128-2139.
57. Krakauer T,. Pentoxifylline inhibits ICAM-1 expression and chemokine production induced by proinflammatory cytokines in human pulmonary epithelial cells. Immunopharmacology 2000; 46: 253-261.
58. Ulanova M, Puttagunta L, Marcet-Palacios M, Duszyk M, Steinhoff U, Duta F, Kim MK, Indik ZK, Schreiber AD, Befus AD,. Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005; 288: L497-507.
59. Huang ZY, Kim MK, Kim-Han TH, Indik ZK, Schreiber AD,. Effect of locally administered Syk si-RNA on allergen-induced arthritis and asthma. Mol. Immunol. 2013; 53: 52-59.
60. Pazdrak K, Young TW, Stafford S, Olszewska-Pazdrak B, Straub C, Starosta V, Brasier A, Kurosky A,. Cross-talk between ICAM-1 and granulocyte-macrophage colony-stimulating factor receptor signaling modulates eosinophil survival and activation. J. Immunol. 2008; 180: 4182-4190.
61. Kavanaugh AF, Davis LS, Nichols LA, et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 1994; 37: 992-999.
62. Shanahan WR Jr,. ISIS 2302, an antisense inhibitor of intercellular adhesion molecule 1. Expert Opin. Investig. Drugs 1999; 8: 1417-1429.
63. Catley MC, Coote J, Bari M, Tomlinson K,. Monoclonal antibodies for the treatment of asthma. Pharmacol. Ther. 2011; 132: 333-351.
64. Weinberger M,. Respiratory infection and asthma: current treatment strategies. Drug Discov. Today 2004; 9: 831-837.
65. Mediratta PK, Sharma KK, Verma V,. A review on recent development of common cold therapeutic agents. Indian J. Med. Sci. 2000; 54: 485-490.
66. Ang LT, Tan LY, Chow VT, Sim MK,. Des-aspartate-angiotensin I exerts antiviral effects and attenuates ICAM-1 formation in rhinovirus-infected epithelial cells. Eur. J. Pharmacol. 2012; 683: 310-315.
67. Traub S, Nikonova A, Carruthers A, Dunmore R, Vousden KA, Gogsadze L, Hao W, Zhu Q, Bernard K, Zhu J, et al. An anti-human icam-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation. PLoS Pathog. 2013; 9: e1003520.